Healthcare · Diagnostics & Research
Latest call day: 2026-10-23 · full consensus board · graded history
Price (daily close, 2026-10-23)
Trailing returns (daily closes)
Today's calls AI
| Medical Devices & Tools · 52-Week-High | UP 100% | 52-Week-High — proximity to the trailing high. DHR ranks #1 of 10 in Medical Devices & Tools (100% bullish percentile, 95% of its 52-week high), so the agent calls it UP for the next session. |
| Medical Devices & Tools · Vol-Adjusted Momentum | UP 100% | Vol-Adjusted Momentum — return per unit of recent volatility. DHR ranks #1 of 10 in Medical Devices & Tools (100% bullish percentile, return/volatility +0.98), so the agent calls it UP for the next session. |
| Pharma & Managed Care · Long-Term Reversal | UP 92% | Long-Term Reversal — year-long losers rebound. DHR ranks #2 of 13 in Pharma & Managed Care (92% bullish percentile, signal -4.8%), so the agent calls it UP for the next session. |
| Medical Devices & Tools · Trend Strength | UP 89% | Trend Strength — OLS slope of log price. DHR ranks #2 of 10 in Medical Devices & Tools (89% bullish percentile), so the agent calls it UP for the next session. |
| Pharma & Managed Care · Mean-Reversion | UP 83% | Mean-Reversion — contrarian on the trailing return. DHR ranks #3 of 13 in Pharma & Managed Care (83% bullish percentile, recent move -0.8%, fading it), so the agent calls it UP for the next session. |
| Medical Devices & Tools · LightGBM | DOWN 78% | LightGBM — a gradient-boosted model fit on this basket's recent features. DHR ranks #6 of 10 in Medical Devices & Tools (78% bearish percentile), so the agent calls it DOWN for the next session. |
| Medical Devices & Tools · Mean-Reversion | UP 78% | Mean-Reversion — contrarian on the trailing return. DHR ranks #3 of 10 in Medical Devices & Tools (78% bullish percentile, recent move -0.8%, fading it), so the agent calls it UP for the next session. |
| Medical Devices & Tools · Momentum | DOWN 78% | Momentum — trailing return (trend-following). DHR ranks #6 of 10 in Medical Devices & Tools (78% bearish percentile, signal +2.9%), so the agent calls it DOWN for the next session. |
| Medical Devices & Tools · Regime Switch | DOWN 78% | Regime Switch — the market looks trending, so it ranked on Momentum. DHR ranks #6 of 10 in Medical Devices & Tools (78% bearish percentile), so the agent calls it DOWN for the next session. |
| Medical Devices & Tools · RSI Mean-Reversion | UP 78% | RSI Mean-Reversion — oversold up / overbought down. DHR ranks #3 of 10 in Medical Devices & Tools (78% bullish percentile, RSI 65), so the agent calls it UP for the next session. |
| Medical Devices & Tools · SOTA Ensemble | UP 78% | SOTA Ensemble — a purged-CV rank ensemble (gradient-boosting + ridge + momentum). DHR ranks #3 of 10 in Medical Devices & Tools (78% bullish percentile), so the agent calls it UP for the next session. |
| Pharma & Managed Care · Bollinger Reversion | UP 75% | Bollinger Reversion — fade moves outside the bands. DHR ranks #4 of 13 in Pharma & Managed Care (75% bullish percentile), so the agent calls it UP for the next session. |
| Pharma & Managed Care · Breakout | DOWN 75% | Breakout — pushing above the prior channel high. DHR ranks #8 of 13 in Pharma & Managed Care (75% bearish percentile, signal -1.8%), so the agent calls it DOWN for the next session. |
Best agents on DHR (graded record)
| Mean-Reversion Agent | 100% | 2/2 correct | UP |
| Medical Devices & Tools · Dual Momentum | 100% | 1/1 correct | UP |
| Medical Devices & Tools · 52-Week-High | 66% | 41/62 correct | UP |
| Pharma & Managed Care · Momentum | 65% | 32/49 correct | UP |
| Pharma & Managed Care · MACD | 65% | 30/46 correct | UP |
| Medical Devices & Tools · Breakout | 64% | 14/22 correct | UP |
| Medical Devices & Tools · Vol-Adjusted Momentum | 63% | 36/57 correct | UP |
| Pharma & Managed Care · Long-Term Reversal | 63% | 53/84 correct | UP |
| Medical Devices & Tools · Donchian | 63% | 37/59 correct | UP |
| Medical Devices & Tools · Meta-Ensemble | 61% | 35/57 correct | UP |
Recent news
| 2026-10-22 | What Does Danaher (DHR) FDA Clearance For AI AFib Detection Mean Now? · yf_tkr_DHR |
| 2026-10-22 | LH vs. DHR: Which Stock Is the Better Value Option? · yf_tkr_DHR |
| 2026-10-22 | Danaher (DHR) Q3 Earnings Fuel Stock Gains On Margin Expansion · yf_tkr_DHR |
| 2026-10-22 | Danaher Q3 Recap: Decent Results, Still A Hold (NYSE:DHR) · Seeking Alpha |
| 2026-10-22 | DHR Q3 deep dive: execution focus and AI strategy underpin improved outlook · yf_tkr_DHR |
| 2026-10-22 | Danaher (DHR) Stock Fair Value Edges Higher After Analysts Lift Targets · yf_tkr_DHR |
How grading works: every call is locked before the open and scored on the session's open→close move — see the methodology.
Open Fortivio.AI →Model-generated predictions with a live graded record — not investment advice. 模型生成的预测，非投资建议。